Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

被引：19
作者：
Flossmann, O.
Jones, R. B.
Jayne, D. R. W.
Luqmani, R. A.
机构：
[1] Univ Oxford, Botnar Res Ctr, Oxford OX3 7LD, England
[2] Addenbrookes Hosp, Vasticulitis Unit, Cambridge CB2 2QQ, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 07期
关键词：
D O I：
10.1136/ard.2005.048900
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：841 / 844
页数：4
相关论文
共 32 条
[1]   Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations [J].
Aries, P. M. ;
Hellmich, B. ;
Voswinkel, J. ;
Both, M. ;
Noelle, B. ;
Holl-Ulrich, K. ;
Lamprecht, P. ;
Gross, W. L. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) :853-858
[2]   Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab) [J].
Arzoo, K ;
Sadeghi, S ;
Liebman, HA .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :922-924
[3]   A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus [J].
Chan, OTM ;
Hannum, LG ;
Haberman, AM ;
Madaio, MP ;
Shlomchik, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (10) :1639-1647
[4]   B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels [J].
Collins, CE ;
Gavin, AL ;
Migone, TS ;
Hilbert, DM ;
Nemazee, D ;
Stohl, W .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)
[5]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
[6]   Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab [J].
Eriksson, P .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (06) :540-548
[7]  
Exley AR, 1998, BRIT J RHEUMATOL, V37, P57
[8]   Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases [J].
Gottenberg, JE ;
Guillevin, L ;
Lambotte, O ;
Combe, B ;
Allanore, Y ;
Cantagrel, A ;
Larroche, C ;
Soubrier, M ;
Bouillet, L ;
Dougados, M ;
Fain, O ;
Farge, D ;
Kyndt, X ;
Lortholary, O ;
Masson, C ;
Moura, B ;
Remy, P ;
Thomas, T ;
Wendling, D ;
Anaya, JM ;
Sibilia, J ;
Mariette, X .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) :913-920
[9]   Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? [J].
Heeringa, P ;
Tervaert, JWC .
KIDNEY INTERNATIONAL, 2004, 65 (05) :1564-1567
[10]   WEGENER GRANULOMATOSIS - AN ANALYSIS OF 158 PATIENTS [J].
HOFFMAN, GS ;
KERR, GS ;
LEAVITT, RY ;
HALLAHAN, CW ;
LEBOVICS, RS ;
TRAVIS, WD ;
ROTTEM, M ;
FAUCI, AS .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :488-498
1234